| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
| 12.11. | ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million | 108 | GlobeNewswire (Europe) | ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3... ► Artikel lesen | |
| 23.10. | ADDvise Group AB (publ): Interim report 2025, January 1-September 30 | 106 | GlobeNewswire (Europe) | Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive.... ► Artikel lesen | |
| 17.07. | ADDvise Group AB (publ): Interim report 2025, January 1-June 30 | 137 | GlobeNewswire (Europe) | In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow... ► Artikel lesen | |
| 11.07. | ADDVISE GROUP AB: ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm | 2 | Cision News | ||
| 09.07. | ADDVISE GROUP AB: Invitation to presentation of interim report April 1 - June 30, 2025 | 1 | Cision News | ||
| 26.05. | ADDvise Group AB (publ): ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year | 1.566 | GlobeNewswire (Europe) | ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will... ► Artikel lesen | |
| 12.05. | ADDvise Group AB (publ): Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs | 141 | GlobeNewswire (Europe) | Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for... ► Artikel lesen | |
| 12.05. | ADDvise Group AB (publ): Report from the annual general meeting of ADDvise Group AB (publ) on 12 May 2025 | 150 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115, has today, on 12 May 2025, held its annual general meeting at the company's premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved... ► Artikel lesen | |
| 09.05. | ADDvise Group AB (publ): Interim report 2025, January 1-March 31 | 154 | GlobeNewswire (Europe) | In the first quarter of 2025, net revenue increased organically with continued good profitability, which shows stable demand in medical technology and laboratory solutions. Cash flow from operating... ► Artikel lesen | |
| 24.04. | New equity right for trading, ADDvise Group AB | 226 | GlobeNewswire | At the request of ADDvise Group AB, equity rights will be traded on First North Growth Market as from 25 April 2025.
Security name:
ADDvise Group AB TO 1 A
Short... ► Artikel lesen | |
| 18.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.03.2025 | 688 | Xetra Newsboard | Das Instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE EO -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2025 und ex Kapitalmassnahme am 19.03.2025 The instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE... ► Artikel lesen | |
| 12.03. | ADDvise Group AB (publ): Report from the extra ordinary general meeting in ADDvise Group AB (publ) | 344 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115 (the "Company"), has held an extraordinary general meeting on 12 March 2025. The general meeting resolved to amend the articles of association, approve... ► Artikel lesen | |
| 20.02. | ADDvise Group AB (publ): Year-end report 2024, January 1-December 31 | 227 | GlobeNewswire (Europe) | The fourth quarter of 2024 showed a turnaround in organic net revenue. In December alone, we are now back at positive organic growth of 4.8%. With new long-term financial targets, we are now taking... ► Artikel lesen | |
| 07.02. | ADDvise Group AB (publ): ADDvise presents preliminary financial information for the fourth quarter of 2024 and updates long-term financial targets | 165 | GlobeNewswire (Europe) | The Board of Directors of ADDvise Group AB ("ADDvise" and the "Company") presents preliminary financial information for the fourth quarter of 2024 and has, in connection therewith, decided to update... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,900 | 0,00 % | Neue 3,250%-Anleihe von Fresenius Medical Care | Stuttgart (www.anleihencheck.de) - Fresenius Medical Care (ISIN DE0005785802/ WKN 578580) hat eine Unternehmensanleihe (ISIN XS3233499089/ WKN A460DH) mit einem Volumen von bis zu 500 Millionen Euro... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,930 | +0,96 % | PRESSESPIEGEL/Unternehmen: SIEMENS HEALTHINEERS, INSTONE, BÖRSE STUTTGART, VOLKSWAGEN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
SIEMENS HEALTHINEERS - Das größte Potenzial sieht Siemens-Healthineers-CEO... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,940 | 0,00 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| UNITEDHEALTH | 278,50 | -0,22 % | Extreme Fear - als Kaufchance? United Health | Alphabet | Starbucks | Meta | Die neuen PCE-Inflationsdaten liegen unter den Erwartungen und erhöhen die Chance auf eine Zinssenkung im Dezember - das FedWatch-Tool springt auf über 85 %. Gleichzeitig bleibt der Fear & Greed Index... ► Artikel lesen | |
| MEDTRONIC | 87,78 | 0,00 % | Medtronic Launches MiniMed 780G In U.S. With Abbott's New Instinct CGM Sensor | DUBLIN (dpa-AFX) - Medtronic (MDT) has begun the full U.S. rollout of the MiniMed 780G insulin delivery system integrated with Abbott's Instinct sensor, following FDA clearance earlier this... ► Artikel lesen | |
| INTUITIVE SURGICAL | 488,05 | -0,08 % | Is Intuitive Surgical's Dominance Safe? 10 Years of Healthcare Upside | ||
| TELADOC HEALTH | 6,505 | +0,62 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| THERMO FISHER | 501,30 | +0,42 % | Thermo Fisher Scientific deepens investment in Asia's biopharma ecosystem | ||
| HIMS & HERS HEALTH | 31,240 | 0,00 % | HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? | ||
| BICO GROUP | 1,784 | +0,17 % | BICO Group AB: Publication of BICO Group AB: Interim report Q3 2025 | Organic sales growth in a continued soft market
Q3 2025 SummaryLife Science Solutions showed 4 percent organic sales growth YoY, which is in line with market performance. SCIENION continued to perform... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 59,46 | -0,07 % | Eurofins: Weekly Report on Share Repurchases From 24th November to 28th November 2025 | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily... ► Artikel lesen | |
| BECTON DICKINSON | 164,85 | +0,61 % | Is Becton, Dickinson and Company Stock Underperforming the Nasdaq? | ||
| ALIGN TECHNOLOGY | 130,00 | +0,12 % | Align Technology (ALGN) Slid as Demand Rebound Expectations Fell Short | ||
| NUGEN MEDICAL DEVICES | 0,024 | -4,03 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| INMODE | 12,215 | -0,33 % | InMode Ltd.: InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins | YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen |